You just read:

U.S. FDA Approves YONDELIS® (trabectedin) for the Treatment of Liposarcoma or Leiomyosarcoma - Two Common Subtypes of Soft Tissue Sarcoma

News provided by

PharmaMar

23 Oct, 2015, 16:30 BST